Autoinflammatory diseases

被引:4
作者
Mosdosi Bernadett [1 ]
Toth Beata [2 ]
机构
[1] Pecsi Tud Egyet, Altalanos Orvostud Kar, Klin Kozpont, Gyermekgyogyaszati Klin, Pecs, Hungary
[2] Debreceni Egyet, Altalanos Orvostud Kar, Lab Med Int, Debrecen, Hungary
关键词
fever; autoinflammatory disorders; inflammasome; interleukin-1; FAMILIAL MEDITERRANEAN FEVER; MEVALONATE KINASE-DEFICIENCY; HEREDITARY PERIODIC FEVER; HYPERIMMUNOGLOBULINEMIA-D; COLCHICINE TREATMENT; NLRP3; INFLAMMASOME; TNF-RECEPTOR; MUTATIONS; AMYLOIDOSIS; DIAGNOSIS;
D O I
10.1556/650.2018.31068
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autoinflammatory diseases are disorders of the innate immune system characterized by recurrent systematic inflammation and serious complications. Dysregulation of inflammasome and overproduction of interleukin-1 play a major role in the pathogenesis of autoinflammatory diseases. The diagnosis of these rare conditions rely on recognising the pattern of presentation and differential diagnosis. Manifestations may include fever, rash, serositis (pleuritis and peritonitis), arthritis, meningitis and uveitis. Secondary amyloidosis may complicate longstanding disease. Advances in our understanding of the molecular and pathophysiological basis of the autoinflammatory diseases have resulted in new treatment strategies. Early diagnosis and effective therapy are critical to prevent irreversible organ damage. The purpose of this review is to describe the major clinical, genetic, and therapeutic features of the most common autoinflammatory syndromes.
引用
收藏
页码:898 / 907
页数:10
相关论文
共 48 条
[1]   Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis [J].
Aganna, E ;
Hawkins, PN ;
Ozen, S ;
Pettersson, T ;
Bybee, A ;
McKee, S ;
Lachmann, H ;
Karenko, L ;
Ranki, A ;
Bakkaloglu, A ;
Besbas, N ;
Topaloglu, R ;
Hoffman, H ;
Hitman, G ;
Woo, P ;
McDermott, M .
GENES AND IMMUNITY, 2004, 5 (04) :289-293
[2]   Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation [J].
Agullo, Luis ;
Malhotra, Sunny ;
Fissolo, Nicolas ;
Montalban, Xavier ;
Comabella, Manuel .
JOURNAL OF NEUROIMMUNOLOGY, 2015, 289 :12-20
[3]   The tumor-necrosis-factor receptor-associated periodic syndrome:: New mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers [J].
Aksentijevich, I ;
Galon, J ;
Soares, M ;
Mansfield, E ;
Hull, K ;
Oh, HH ;
Goldbach-Mansky, R ;
Dean, J ;
Athreya, B ;
Reginato, AJ ;
Henrickson, M ;
Pons-Estel, B ;
O'Shea, JJ ;
Kastner, DL .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (02) :301-314
[4]   The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response [J].
Baroja-Mazo, Alberto ;
Martin-Sanchez, Fatima ;
Gomez, Ana I. ;
Martinez, Carlos M. ;
Amores-Iniesta, Joaquin ;
Compan, Vincent ;
Barbera-Cremades, Maria ;
Yaguee, Jordi ;
Ruiz-Ortiz, Estibaliz ;
Anton, Jordi ;
Bujan, Segundo ;
Couillin, Isabelle ;
Brough, David ;
Arostegui, Juan I. ;
Pelegrin, Pablo .
NATURE IMMUNOLOGY, 2014, 15 (08) :738-+
[5]   Familial Mediterranean Fever in the World [J].
Ben-Chetrit, Eldad ;
Touitou, Isabelle .
ARTHRITIS CARE & RESEARCH, 2009, 61 (10) :1447-1453
[6]   Peritoneal adhesions and intestinal obstructions in patients with familial Mediterranean fever - Are they more frequent? [J].
Berkun, Yackov ;
Ben-Chetrit, Eli ;
Klar, Aharon ;
Ben-Chetrit, Eldad .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2007, 36 (05) :316-321
[7]  
Bernot A, 1997, NAT GENET, V17, P25
[8]   Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: A prospective, open-label, dose-escalation study [J].
Bulua, Ariel C. ;
Mogul, Douglas B. ;
Aksentijevich, Ivona ;
Singh, Harjot ;
He, David Y. ;
Muenz, Larry R. ;
Ward, Michael M. ;
Yarboro, Cheryl H. ;
Kastner, Daniel L. ;
Siegel, Richard M. ;
Hull, Keith M. .
ARTHRITIS AND RHEUMATISM, 2012, 64 (03) :908-913
[9]   IDIOPATHIC RECURRENT PERICARDITIS REFRACTORY TO COLCHICINE TREATMENT CAN REVEAL TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME [J].
Cantarini, L. ;
Lucherini, O. M. ;
Cimaz, R. ;
Baldari, C. T. ;
Bellisai, F. ;
Paccani, S. Rossi ;
Pasini, F. Laghi ;
Capecchi, P. L. ;
Sebastiani, G. D. ;
Galeazzi, M. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (04) :1051-1058
[10]  
Caso F, 2013, INT J RHEUMATOL, V2013, P1